159 related articles for article (PubMed ID: 25182689)
21. [Evaluation of the prognostic value of MIPSS70-plus in Chinese patients with primary myelofibrosis].
Yan X; Li B; Qin TJ; Qu SQ; Pan LJ; Wu JY; Liu D; Xiao ZJ; Xu ZF
Zhonghua Xue Ye Xue Za Zhi; 2021 Jan; 42(1):15-20. PubMed ID: 33677863
[No Abstract] [Full Text] [Related]
22. Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2013 Feb; 88(2):141-50. PubMed ID: 23349007
[TBL] [Abstract][Full Text] [Related]
23. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.
Barbui T; Thiele J; Passamonti F; Rumi E; Boveri E; Ruggeri M; Rodeghiero F; d'Amore ES; Randi ML; Bertozzi I; Marino F; Vannucchi AM; Antonioli E; Carrai V; Gisslinger H; Buxhofer-Ausch V; Müllauer L; Carobbio A; Gianatti A; Gangat N; Hanson CA; Tefferi A
J Clin Oncol; 2011 Aug; 29(23):3179-84. PubMed ID: 21747083
[TBL] [Abstract][Full Text] [Related]
24. Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasia.
Sagaster V; Jäger E; Weltermann A; Schwarzinger I; Gisslinger H; Lechner K; Geissler K; Oehler L
Haematologica; 2003 Nov; 88(11):1204-12. PubMed ID: 14607748
[TBL] [Abstract][Full Text] [Related]
25. Unique features of primary myelofibrosis in Chinese.
Xu Z; Gale RP; Zhang Y; Qin T; Chen H; Zhang P; Zhang T; Liu L; Qu S; Xiao Z
Blood; 2012 Mar; 119(11):2469-73. PubMed ID: 22262778
[TBL] [Abstract][Full Text] [Related]
26. Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis.
Lucijanic M; Mitrovic Z; Cicic D; Prka Z; Pejsa V; Livun A; Stoos-Veic T; Romic Z; Zivkovic M; Lucijanic I; Fabris Z; Kusec R
Int J Hematol; 2018 Feb; 107(2):166-172. PubMed ID: 29022201
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.
Guglielmelli P; Rotunno G; Pacilli A; Rumi E; Rosti V; Delaini F; Maffioli M; Fanelli T; Pancrazzi A; Pieri L; Fjerza R; Pietra D; Cilloni D; Sant'Antonio E; Salmoiraghi S; Passamonti F; Rambaldi A; Barosi G; Barbui T; Cazzola M; Vannucchi AM
Am J Hematol; 2016 Sep; 91(9):918-22. PubMed ID: 27264006
[TBL] [Abstract][Full Text] [Related]
28. Prognostic risk models for transplant decision-making in myelofibrosis.
Hernández-Boluda JC; Pereira A; Correa JG; Alvarez-Larrán A; Ferrer-Marín F; Raya JM; Martínez-López J; Velez P; Pérez-Encinas M; Estrada N; García-Gutiérrez V; Fox ML; Payer A; Kerguelen A; Cuevas B; Durán MA; Ramírez MJ; Gómez-Casares MT; Mata-Vázquez MI; Mora E; Gómez M; Cervantes F
Ann Hematol; 2018 May; 97(5):813-820. PubMed ID: 29396714
[TBL] [Abstract][Full Text] [Related]
29. Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis--prognostic relevance is independent of IPSS or karyotype.
Tefferi A; Siragusa S; Hussein K; Schwager SM; Hanson CA; Pardanani A; Cervantes F; Passamonti F
Am J Hematol; 2010 Jan; 85(1):14-7. PubMed ID: 20029953
[TBL] [Abstract][Full Text] [Related]
30. Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management.
Tefferi A
Am J Hematol; 2011 Dec; 86(12):1017-26. PubMed ID: 22086865
[TBL] [Abstract][Full Text] [Related]
31. CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients.
Tefferi A; Guglielmelli P; Lasho TL; Rotunno G; Finke C; Mannarelli C; Belachew AA; Pancrazzi A; Wassie EA; Ketterling RP; Hanson CA; Pardanani A; Vannucchi AM
Leukemia; 2014 Jul; 28(7):1494-500. PubMed ID: 24496303
[TBL] [Abstract][Full Text] [Related]
32. Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type.
Bacigalupo A; Soraru M; Dominietto A; Pozzi S; Geroldi S; Van Lint MT; Ibatici A; Raiola AM; Frassoni F; De Stefano F; Verdiani S; Casarino L; Barosi G
Bone Marrow Transplant; 2010 Mar; 45(3):458-63. PubMed ID: 19718055
[TBL] [Abstract][Full Text] [Related]
33. Patient-specific comorbidities as prognostic variables for survival in myelofibrosis.
Sochacki AL; Bejan CA; Zhao S; Patel A; Kishtagari A; Spaulding TP; Silver AJ; Stockton SS; Pugh K; Dorand RD; Bhatta M; Strayer N; Zhang S; Snider CA; Stricker T; Nazha A; Bick AG; Xu Y; Savona MR
Blood Adv; 2023 Mar; 7(5):756-767. PubMed ID: 35420683
[TBL] [Abstract][Full Text] [Related]
34. [The application of a new prognostic score system for 435 cases of primary myelodysplastic syndrome diagnosed with WHO classification].
Wang XQ;
Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):633-7. PubMed ID: 19954053
[TBL] [Abstract][Full Text] [Related]
35. Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution.
Tefferi A; Huang J; Schwager S; Li CY; Wu W; Pardanani A; Mesa RA
Cancer; 2007 May; 109(10):2083-8. PubMed ID: 17407134
[TBL] [Abstract][Full Text] [Related]
36. [A study of clinical characteristics and prognosis of primary myelofibrosis patients with thrombocytopenia in varied degrees].
Xu ZF; Qin TJ; Zhang HL; Fang LW; Hu NB; Pan LJ; Qu SQ; Li B; Yan X; Shi ZX; Huang HJ; Liu D; Cai YN; Zhang YD; Zhang PH; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2019 Jan; 40(1):12-16. PubMed ID: 30704222
[No Abstract] [Full Text] [Related]
37. High absolute basophil count is a powerful independent predictor of inferior overall survival in patients with primary myelofibrosis.
Lucijanic M; Livun A; Stoos-Veic T; Pejsa V; Jaksic O; Cicic D; Lucijanic J; Romic Z; Orehovec B; Aralica G; Miletic M; Kusec R
Hematology; 2018 May; 23(4):201-207. PubMed ID: 28906207
[TBL] [Abstract][Full Text] [Related]
38. Prognostic implications of low transferrin saturation in patients with primary myelofibrosis.
Lucijanic M; Prka Z; Pejsa V; Stoos-Veic T; Lucijanic J; Kusec R
Leuk Res; 2018 Mar; 66():89-95. PubMed ID: 29407589
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetic studies and their prognostic contribution in 565 Chinese patients with primary myelofibrosis.
Li B; Xu J; Li C; Gale RP; Xu Z; Qin T; Zhang Y; Huang G; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
Am J Hematol; 2014 Nov; 89(11):1043-6. PubMed ID: 25132428
[TBL] [Abstract][Full Text] [Related]
40. The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.
Scott BL; Gooley TA; Sorror ML; Rezvani AR; Linenberger ML; Grim J; Sandmaier BM; Myerson D; Chauncey TR; Storb R; Buxhofer-Ausch V; Radich JP; Appelbaum FR; Deeg HJ
Blood; 2012 Mar; 119(11):2657-64. PubMed ID: 22234678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
